AASLD Updates Clinical Guidance for Liver Biopsies
The new expert opinion from the organization formally includes endoscopic ultrasound-guided biopsy as a clinical option.
Updated on Oct. 16, 2026 in Life Sciences
Live Poll
Do you trust medical guidelines that remove specific clinical thresholds for procedures like liver biopsies?
The American Association for the Study of Liver Diseases has released its first updated guidance on liver biopsies since 2009. The new documentation formally incorporates endoscopic ultrasound-guided liver biopsy as a standard procedural choice.
Why it matters
The organization developed this Expert Practice Opinion to offer clear medical recommendations in clinical areas where evidence is limited or rapidly changing. It provides updated procedural standards to assist clinicians in navigating complex patient factors like coagulopathy.
The guidance recommends a minimum specimen length of 1.5 centimeters and at least 11 portal tracts in pathology reports. It also notes an interobserver concordance rate of 78 percent for fibrosis staging among pathologists.
The players
American Association for the Study of Liver Diseases
The AASLD is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease.
The details
The writing group performed a targeted literature review to create these standards, which omit specific international normalized ratio or platelet thresholds for performing biopsies. Imaging localization is also newly recommended during percutaneous liver procedures in adults.
Timeline
The previous liver biopsy guidance was published in 2009.
The Expert Practice Opinion was published in Hepatology on October 7, 2026.
AASLD issued a news release regarding the document on October 15, 2026.
The news article detailing the update was published on October 16, 2026.
Deeper Dive
Updating the 2009 AASLD liver biopsy guidelines marks a departure from static diagnostic protocols that had not been formally reviewed in over 17 years.
The standardization of biopsy techniques and specimen sizes may lead to more consistent pathology reports for patients undergoing liver evaluation. These updates help doctors select the safest biopsy method based on individual patient risks like ascites.
The takeaway
Clinicians can now reference this updated framework to navigate diagnostic challenges with more consistency. The inclusion of new ultrasound-guided options offers providers greater flexibility in tailoring procedures to patient-specific health factors.
Further reading
Learn more about the latest advancements in the field in our Life Sciences section.
Source note: This article includes information reported by Hcplive.
Live Poll
Do you trust medical guidelines that remove specific clinical thresholds for procedures like liver biopsies?
